Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
584 participants
INTERVENTIONAL
2018-07-15
2025-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Sleep Disturbance in Alzheimer Disease
NCT00831298
Toward a Real-time Access to Sleepers' Mental Content
NCT05452733
Interaction of Chronic Sleep Restriction and Circadian Misalignment on Sleep and Neuro-cognitive Performance
NCT00438438
Age-related Changes in Sleep-wake Regulation
NCT03813082
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
NCT03256539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Exp 2: The investigators will examine the rate of memory decay between encoding and sleep using two probes of declarative memory (word-pair learning and visuo-spatial learning).
Exp 3: The investigators will provide additional opportunity for encoding of the word-pair and visuo-spatial learning tasks.
Exp 4: Using neuroimaging, the investigators will examine neural engagement during encoding and performance following intervals of sleep and wake.
Exp 5: The investigators will examine the rate of decay of motor sequence learning.
Exp 6: The investigators will examine whether enhanced training ('overtraining') improves sleep-dependent memory consolidation for older adults.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sleep
Individuals will either nap (Exps 1, 4) or have overnight sleep (Exps 2, 3, 5, 6)
Sleep
Participants will sleep (either a mid-day nap or normal overnight sleep)
Wake
Individuals will stay awake for the same amount of time as they slept in the sleep condition
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sleep
Participants will sleep (either a mid-day nap or normal overnight sleep)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy sleeper
* No diagnosed sleep or neurodegenerative disorder
Exclusion Criteria
2. Past diagnosis neurological illness or head injury
3. Reported average sleep per night \< 5 or \> 9 hrs
4. Current employment involving shift work or an inability to keep a regular sleep schedule during the week prior to testing
5. Current use of psychotropic, recreational drugs, or sleep-altering medications (sleep medications, cold medicines within the past week, clonidine, sympathomimetic stimulants)
6. Daily caffeine intake of \> 4 cups (coffee, tea, colas)
7. Weekly alcohol intake of \> 10 cups
8. Pregnancy or \< 12 months post-partum
9. History of bipolar disorder, mania, or current evidence of depression as measured by Beck Depression Inventory score \> 25
10. Abnormal sleep (e.g., shift work, travel across \>2 time zones within the past 3 months).
11. Diagnosis of any Axis I disorder, neurological illness or head injury (according to Demographic and Health History form);
12. Score indicative of cognitive dysfunction (subtest scores \< 40)
13. Beck Depression Scale score indicative of depression (\> 19).
Additionally, individuals will be excluded from magnetic resonance imaging studies (Exps 1, 4) for:
1. Left handed or ambidextrous
2. Claustrophobia
3. Presence of metal (thoroughly screened via questionnaire and metal detector)
4. Pregnancy
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Amherst
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rebecca Spencer
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Massachusetts
Amherst, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-4290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.